a b s t r a c t a r t i c l e i n f o
Introduction
Slaughterhouses as well as the processing of meats generate a significant amount of solid and liquid by-products. Wholesalers, retailers and renderers also produce large amounts of by-products. So, millions of tons of processing wastes are produced every day and the problem is the disposal of such wastes, which remains a huge problem for the processors. The disposal of processing by-products and wastes incurs considerable cost to processors for their treatment according to strict regulations. Of course, there are industrial systems to treat and reduce by-products but there is a growing awareness that most times these by-products are under-utilized and represent a valuable resource if treated in the correct manner.
It is no longer practical to discard by-products and wastes, especially when a significant amount of valuable raw materials have a strong economic potential like the production of new products and functional ingredients with a significant added-value (Toldrá & Reig, 2011; Zhang, Xiao, Samaraweera, Lee, & Ahn, 2010) . It is desirable to process all by-products into valuable products, for human foods, pet foods, animal feeds, pharmaceuticals, or fertilizer and lately for biodiesel generation. New technologies and uses for meat byproducts have been developed around the world but most times they are difficult to be implemented. The reason is the difficulties Meat Science 92 (2012) [290] [291] [292] [293] [294] [295] [296] found to combine the use of innovative technology, processing methods, and adequate marketing of the product.
Adding value to meat by-products implies a degree of innovation that makes a by-product that could be considered as waste, to be used as raw material subjected to further processing into edible food items desirable to consumers (Ockerman & Basu, 2004a) or inedible products with economic profitability (e.g. plastics, pharmaceuticals, energy) (Ockerman & Basu, 2004b; Pearl, 2004 ). In the case of edible items, meat by-products constitute an excellent source of nutrients like essential amino acids, minerals and vitamins (Aristoy & Toldrá, 2011; García-Llatas, Alegría, Barberá, & Farré, 2011; Honikel, 2011; Kim, 2011) . Such added value can be obtained in terms of shelf stability, improved technological functions (flavoring compounds, water bonding agents, emulsifiers), better sensory quality (color, texture, flavor) or even more convenience. Another alternative is to produce functional ingredients like bioactive peptides and antioxidants. A good example is blood that has a long history of use in Europe and Asia as an ingredient in traditional foods like blood sausages, puddings, blood soups and crackers. Blood serves several technological functions such as the increase in protein levels, and the enhancement of the water binding and emulsification capacity (Mandal, Rao, Kowale, & Pal, 1999; . On the contrary, blood products use to be discarded in the USA as an unwanted by-product; for instance, beef plasma is no longer used in the United States for surimi or other food preparations.
Meat industry is using science and innovation to add value to animal by-products far beyond its usual profitability based on hides and internal organs. Appropriate research and development activity can help to convert animal by-products into key components (bioactive molecules) in scientific, medical, and technological advances. In summary, the processing of by-products can convert a product of low value, or even having relevant disposal costs, into a product capable of covering all the processing and disposal costs, and reducing the environmental damage. A diagram showing the main routes for applications of meat by-products is shown in Fig. 1 . This manuscript reviews the latest innovations to add value to edible meat by-products far beyond its usual profitability.
Safety issues
Apart from strict hygiene considerations, there are other recent issues that deserve attention when treating meat by-products. Bovine spongiform encephalopathy (BSE) is a disease that was first detected in 1982 in UK. It affects adult cattle; BSE has not been detected in animals younger than 30 months. BSE belongs to a family of diseases known as transmissible spongiform encephalopathies (TSEs), which result from the build-up of abnormal prion proteins in the brain and central nervous system. A TSE disease that affects humans is the Variant Creuzfeldt-Jacob Disease (vCJD) which causes death. Because of this disease, certain tissues of cattle (spleen, tonsils, intestine, mesentery, spinal cord and full head), sheep and goats (full head, ileum, spleen and spinal cord if a permanent incisor tooth erupted through the gums or are aged over 12 months) that are most likely to contain the BSE agent are considered to be specified risk materials and they must be removed and destroyed in order to avoid their inclusion in either the human or animal food chains. In countries with risk of BSE, the bones from beef, sheep and goats are also considered to be specified risk materials and they are also forbidden for the production of mechanically recovered meat. Sheep and goats may suffer from scrapie which is another TSE disease that, even though not affecting humans, may mask BSE detection. In the European Union, the rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies are described in (FDA, 2004 ) also announced new rules to prevent the establishment and spread of bovine spongiform encephalopathy (BSE) in the United States, including a prohibition on the use of high-risk, cattle-derived materials that can carry the BSE agent which are defined as specified risk material. These materials are brain, skull, eyes, trigeminal ganglia, spinal cord, vertebral column and the dorsal root ganglia of cattle more than 30 months of age and also the tonsils and the distal ileum of the small intestine of cattle of any age. The small intestine of all cattle, and mechanically separated meat from beef are also banned.
Edible meat by-products as human food
The consideration of by-product depends on the market demand. So, some non-carcass products that are considered inedible in a country can be considered as precious products in other countries (Ockerman & Basu, 2004a; Spoonger, 1988) . By-products such as blood, liver,
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Meat processing lung, heart, kidney, brains, spleen and tripe have good nutritive value (Anderson, 1988; Honikel, 2011) and constitute part of the diet in different countries worldwide (Nollet & Toldrá, 2011) . For instance, liver is very rich in vitamins (Kim, 2011) while liver and kidney contain a wide variety of minerals and trace elements (García-Llatas et al., 2011) even though cholesterol content is quite high (Bragagnolo, 2011) . Other products rich in fat tissue like lard or tallow contribute mostly to energy intake. It must be taken into account that the functions and usefulness of some types of organs depend on the animal species from which they are obtained due to fluctuations in nutrients content. For instance, vitamin A may vary from 50,000 RE μg for heart lamb, to 20,000 RE μg for pork heart or 18,000 RE μg for chicken heart (Honikel, 2011) .
Some examples of typical consumption in certain countries of meat trimmings, fatty tissues, horns, hoofs, feet, skull, and organs of harvested animals are briefly described in Table 1 . In addition to typical uses in traditional foods, meat by-products have been the object of innovative applications that are described below.
Blood and blood products
Typical composition of bovine blood consists of 80.9% water, 17.3% protein, 0.23% lipid, 0.07% carbohydrate, and 0.62% minerals (Duarte, Carvalho Simoes, & Sgarbieri, 1999) . Blood is mostly obtained from bovine and porcine sources and is made up of the cellular fraction (red blood cells, white blood cells and platelets) and the plasma fraction .
Blood proteins, especially those found in the plasma fraction, have relevant technological properties like gelation, foaming agents and emulsification that prompted the use of blood-derived products as value-added ingredients in the food industry and as dietary supplements . For example, fractionated plasma proteins like immunoglobulins, fibrinogen and serum albumin, may be added to food and feed ingredients due to their good gelation and emulsification properties (Cofrades, Guerra, Carballo, Fernández-Martin, & Jiménez-Colmenero, 2000) . Some of the plasma proteins have shown good cross-linking ability of major proteins and protease inhibitory activity (Kang & Lanier, 1999) or used to enrich in protein products like pasta (Yousif, Cranston, & Deeth, 2003) . Other precipitated blood plasma compounds like fibrinogen and the enzyme thrombin are used under the trade mark fibrimex® (Harimex, The Netherlands) as a binder for meat processing to manufacture restructured meat products. When both thrombin and fibrinogen are mixed and applied to the surfaces of meat pieces, the thrombin enzyme converts soluble fibrinogen into insoluble fibrin polymer giving rise to a half-staggered structure called the protofibril that finally aggregates to form fibers and yielding a three-dimensional network fibrin clot (Lennon, McDonald, Moon, Ward, & Kenny, 2010; Ryan, Mockros, Weisel, & Lorand, 1999) . The resulting gel network gives meat emulsions with modified physicochemical and textural characteristics, increasing the hardness and springiness (Herrero et al., 2007) . The binding strength depends on several factors like the pH and temperature of the meat, the moisture and in the case of restructured meat also the size of meat cuts (binding is stronger for larger particle size) and the direction of meat fibers (Boles & Shand, 1999; Chen & Lin, 2002) . The hydrolysis of defibrinated bovine plasma with either commercial enzymes like alcalase or flavorzyme resulted in a mixture of peptides with molecular masses less than 6.50 kDa. The knowledge of the molecular weight distribution is relevant in trying to predict the potential allergenicity, biological activity, taste of the hydrolyzate and the types of volatile compounds generated during Maillard reaction (Wanasundara, Amarowicz, Pegg, & Shand, 2002) .
There are not so many applications in the case of the cellular fraction which is rich in red blood cells, probably due to the heme component of hemoglobin that imparts a dark color and adverse flavor to the product (Duarte et al., 1999) or hygienic reasons . It must be remembered that despite hygienic precautions, the microbial contamination of blood may remain relatively high, making necessary the application of preservation methods to minimize the total microbiota in the preserved blood .
The cellular fraction may be used in the meat industry as a color enhancer for sausages . A better alternative to avoid sensory adverse effects is to remove hemoglobin to produce globin or also known as decolorized blood that exhibits relevant technological functions for replacing fat in meat products Viana, Silva, Delvivo, Bizzotto, & Silvestre, 2005) .
The enzymatic digestion of bovine hemoglobin produces heme iron polypeptide which is commercialized for improving iron absorption (Nissenson et al., 2003 ). An heme-iron enriched peptide product was produced through a two stage enzymatic hydrolysis with commercial endo-and exo-peptidases to reach a high degree of hydrolysis, within the range 30-40% (In, Chae, & Oh, 2002) . The heme/ peptide ratio increased with the molecular weight cut-off of the dialysis membrane reaching a ratio of 10% with ultrafiltration and diafiltration on a pilot scale. The obtained heme-enriched peptides were reported to contain higher iron content than hemoglobin constituting an interesting way to prepare heme-iron for the fortification of commonly consumed foods and thus prevention of iron deficiency in populations at risk.
Different types of reactors have been designed to carry out blood hemoglobin hydrolysis with simultaneous extraction of the hydrolyzate. Membrane-ultrafiltration reactors have been reported for such purpose (Kapel et al., 2003; Vanhoute et al., 2010) and more recently, immobilized reactors with pepsin immobilized on a mineral support like alumina (Ticu et al., 2005) .
Proteins: generation of bioactive peptides
The proteolytic activity during meat processing generates a large amount of peptides and free amino acids through proteolysis (Toldrá, 2006) . Endogenous muscle enzymes like calpains and cathepsins in a first stage followed by the action of peptidylpeptidases are responsible for such proteolysis (Arihara, 2006a; Mora et al., 2009; Sentandreu & Toldrá, 2007) . Apart from the endogenous generation, peptides can also be industrially obtained from meat protein wastes (trimmings, organs, collagen, hemoglobin) through hydrolysis with specific commercial proteases like papain, bromelain, thermolysine, pronase or proteinase K (Vercruysse, Van Camp, & Smagghe, 2005) . The enzymatic reaction can take place either in a batch-fed reactor or in a continuous way using an ultrafiltration membrane reactor. The product is then submitted to fractionation and partial purification either by filtration or chromatographic techniques (Arihara, 2006b) . A scheme for such industrial production is shown in Fig. 2 . Hundreds of peptides are released but only a few, known as bioactive peptides, are of interest because they are able to exert a determined health benefit to the consumer through different types of bioactivity like antihypertensive activity, antioxidant activity or opioid activity among others (Arihara & Ohata, 2010) . The inhibition of the angiotensin I-converting enzyme (ACE) probably constitutes the most relevant bioactivity. This enzyme participates in the renin-angiotensin system where angiotensin I is converted into angiotensin II that constricts the arteries and, as a consequence, increases the blood pressure. An effective way to reduce blood pressure is through the inhibition of ACE (Ahmed & Mugurama, 2010 ). In any case, ACE inhibitory activity in vitro effects does not mean an in vivo effect. The reason is that peptides must reach the cardiovascular system in an intact form (e.g. not being affected by digestive human proteases and being absorbed through the intestinal wall into the blood). It has been reported that the bioactivity intensity is inversely correlated to the peptide length (Vermeirssen, Van Camp, & Verstraete, 2004) . Therefore, the peptides that can inhibit ACE in vitro and further exert antihypertensive effect in vivo have shown great promise in the development of a novel therapeutics and functional food for preventing hypertension.
A number of bioactive peptides resulting from meat proteins hydrolysis have been reported in recent literature. The simulated digestion of pork meat proteins with gastrointestinal proteases like pepsin, trypsin, chimotrypsin or pancreatin releases peptides that showed in vitro and in vivo antihypertensive activity when assayed with spontaneously hypertensive rats. In fact, some of those peptides consisting of two pentapeptides from titin (Lys-Ala-Pro-Val-Ala and Pro-ThrPro-Val-Pro) and a tripeptide from nebulin (Arg-Pro-Arg), exerted a significant blood pressure decrease in the rats just after 8 h of administration (Escudero, Sentandreu, Arihara, & Toldrá, 2010; Escudero, Sentandreu, & Toldrá, 2010; Escudero, 2012) . Similar findings were reported for peptides generated from chicken breast proteins (Saiga et al., 2006 ) and a nonapeptide derived from porcine troponin C (Katayama et al., 2004) . A few peptides with good in vitro and in vivo ACE-inhibitory activity against spontaneous hypertensive rats were reported from chicken collagen hydrolyzate obtained with a protease from Aspergillus oryzae (Saiga et al., 2008) .
The thermolysin hydrolysis of pork meat proteins revealed two pentapeptides (Met-Asn-Pro-Pro-Lys and Ile-Thr-Thr-Asn-Pro) and six tripeptides (Met-Asn-Pro, Asn-Pro-Pro, Pro-Pro-Lys, Ile-Thr-Thr, Thr-Thr-Asn and Thr-Asn-Pro) with antihypertensive activity (Arihara, Nakashima, Mukai, Ishikawa, & Itoh, 2001) . Similar peptides were obtained with thermolisin hydrolysis of myosin (Nakashima, Arihara, Sasaki, Ishikawa, & Itoh, 2002) . However, no in vivo activity results were provided so that there is a lack of evidence that these peptides would remain unaltered by digestive human proteases and be absorbed through the intestinal wall.
A bovine gelatin hydrolyzate that was further hydrolyzed with thermolysin, was reported to show an intense in vitro angiotensin Iconverting enzyme inhibitory activity but also in vivo blood-pressure lowering effect in spontaneously rats. In fact, seven di and tripeptides (Ala-Gly, Ala-Gly-Pro, Val-Gly-Pro, Pro-Tyr, Gln-Tyr, Asp-Tyr and IleTyr) were identified as being contributors to the antihypertensive effect (Herregods et al., 2011) . On the other hand, the gelatin hydrolyzate without further thermolisin hydrolysis did not show any effect (Herregods et al., 2011) .
A number of bioactive peptides have been reported from peptic bovine hemoglobin hydrolyzates. Two potent peptides LGFPTTKTYFPHF and VVYPWT, corresponding respectively to the 34-46 fragment of the α chain and the 34-39 fragment of the β chain of porcine hemoglobin, with in vitro inhibitory activity against the angiotensin converting enzyme (ACE) and having IC50 values of 4.92 and 6.02 μM, respectively, were identified (Yu et al., 2006) . These peptides are mostly located around N-and C-terminal regions of α and β chains. However, no in vivo activity results have been provided and thus there is no evidence that these peptides might be absorbed intact or transported into the cell unaltered.
Other bioactive hemoglobin-derived peptides include bradykininpotentiating peptide (Lignot, Froidevaux, Nedjar-Arroume, & Guillochon, 1999) , opioid peptides (Froidevaux, Vanhoute, Lecouturier, Dhulster, & Guillochon, 2008; Piot, Zhao, Guillochon, Ricart, & Thomas, 1992) , analgesic peptides (Zhao, Molina, & Piot, 1997) and antioxidant peptides (Chang, Wu, & Chiang, 2007) . For instance, porcine hemoglobin hydrolyzed with commercial proteases (alcalase followed by flavorenzyme) exerted good antioxidant activities, especially ferrous ion chelating ability and DPPH radical scavenging activity being correlated to the larger molecular weight peptides fraction collected after gel filtration (Chang et al., 2007) .
Antioxidant and free radical scavenging peptides with in vitro and in vivo activity were obtained through hydrolysis of pork myofibrillar proteins with papain (Arihara, 2006b; Saiga, Tanabe, & Nishimura, 2003) . Furthermore, 3 peptides (Asp-Leu-Tyr-Ala, Ser-Leu-Tyr-Ala and Val-Trp) with an anti-fatigue effect as observed with laboratory rats could be isolated and identified (Arihara, 2006b) . Protein hydrolyzates with molecular size below 3000 Da showed an hypocholesterolemic effect observed in laboratory rats probably by interfering the esteroid absorption (Nagaoka, 2006) . Some commercial applications of bioactive peptides in the fish industry have been reported (Lee, Barrow, Kim, Miyashita, & Shahidi, 2011) . Such applications include hydrolyzed bonito products like PeptACE (Natural Factors), Bonito Peptide (Ortho Molecular Products), Levenorm (Ocean Nutrition Canada) and bioactive peptides from fish proteins (Matís -Icelandic Food and Biotech R&D), making it a real possibility that also commercial applications from meat byproducts can be expected in the near future. 
Protein: generation of antimicrobial peptides
The first identification of a peptide in bovine hemoglobin with antibacterial activity corresponded to the fragment 33-61 of the α-chain of bovine hemoglobin (Fogac et al., 1999) . Such peptide was active against Gram-positive bacteria and fungus isolated from the hemolymph of a tick parasitizing the bovines (Boophilus microplus) (Fogac et al., 1999) . Another four antimicrobial peptides active against Micrococcus luteus A270, Listeria innocua, Escherichia coli and Salmonella enteritidis were isolated from peptic digested bovine hemoglobin at low degree of hydrolysis (Daoud et al., 2005; NedjarArroume et al., 2006) . Three peptides corresponded to fragments of the α chain of the bovine hemoglobin (α107-141, α137-141, and α133-141) and one from the β chain (β126-145). It was necessary to clarify if almost all of the hemoglobin was effectively able to exhibit antimicrobial activity or if these peptides contained a common part or structure giving the biological activity. Thus, it was reported that all active peptides derived from α 107-141 contained the necessary KYR sequence for the antimicrobial activity, which is the minimal antimicrobial sequence from the hemoglobin α-chain (Catiau et al., 2011) . Similarly, the peptide β114-145 and its peptic derivatives containing the RYH sequence were found as the most antimicrobial peptides, especially the RYH peptide which was the shortest one (Catiau et al., 2011) .
Twenty-four active peptides were located in the α chain and were classified into three families: α1 derived from peptide α 1-32, α2 derived from peptide α 33-98, and α3 derived from peptide α 107-141. Six active peptides were located in the β chain and were classified into two families; β1 and β2 derived from β 1-30 and β 114-145 peptides, respectively (Nedjar-Arroume et al., 2008) .
The pepsin hydrolysis conditions were changed by using 40% methanol, 30% ethanol, 20% propanol or 10% butanol. The selective and restrictive hydrolyzate of hemoglobin contained only 29 peptides. 26 peptides showed an antibacterial activity against Micrococcus luteus, Listeria innocua, and Escherichia coli with a minimum inhibitory concentration (MIC) from 187.1 to 1 μM. Among them, 13 peptides were obtained under those new hydrolysis conditions (Adje et al., 2011) . Furthermore, the hydrolysis of bovine hemoglobin with pig pepsin in the presence of 30% ethanol released several peptides that were identified as TKAVEHLDDLPGALSELSDLHAHKLRVDPVNFKLL SHSLL, LDDLPGAL-SELSDLHAHKLRVDPVNFKLLSHSL, KLLSHSL, and LLSHSL. They correspond respectively to the 67-106, 73-105, 99-105, and 100-105 fragments of the α chain of bovine hemoglobin. These peptides have an antibacterial activity against Kocuria luteus A270, Listeria innocua, Escherichia coli, and Staphylococcus aureus with a MIC between 187.1 and 35.2 μM. On the other hand, these peptides also displayed inhibitory activity against the angiotensin converting enzyme (ACE) with an IC50 range from 42.55 to 1095 μM. (Adje, Balti, Kouach, Guillochon, & Nedjar-Arroume, 2011) .
Proteins: other food applications
Gelatin is a water-soluble animal protein produced through the hydrolysis of collagen. Gelatin is rich in glycine and proline but poor in tryptophan and methionine. Gelatin has good gel-forming ability that makes it of interest in the food industry for a wide variety of applications like desserts, candies, bakery, jellied meat, ice cream and dairy products. Collagen is quite abundant in the carcass and can be extracted from the animal skin, bones, tendons and ossein. The extraction of gelatin follows a four stage process consisting of the selection of the collagen content in the raw material, the removal of noncollagen materials, the controlled hydrolysis of collagen into gelatin and finally the recovery and drying of gelatin (Ockerman & Basu, 2006) . Typical food industry applications of gelatin are found in bakery, dairy and meat products as clarifying agent, stabilizer or protective coating material (Djagny, Wang, & Xu, 2001 ).
Proteins recovered from the animal rendering process (e.g., bloodmeal, bonemeal or meat) are used to produce protein based foams. These foams are derived from hydrolyzed proteins with the objective to obtain a product with improved physical properties (e.g., reduced surface tension, increased foamability and foam stability) (Bressler, 2009 ). In other cases, hydrolyzed proteins, either chemically or enzymatically, are used as flavor ingredients because they contain small peptides and free amino acids with flavoring properties. These hydrolyzates may also react with reducing sugars to generate relevant flavors. Some dipeptides (Glu-Glu and Glu-Val) and tripeptides (Ala-Asp-Glu, Ala-Glu-Asp, Ser-Pro-Glu and Asp-Glu-Glu) having umami taste were obtained after the hydrolysis of chicken protein extracts with bromelain (Maehashi, Matsuzaki, Yamamoto, & Udaka, 1999) .
Feed and pet food applications
One of the traditional uses of raw and rendered animal byproducts has been its incorporation as ingredients in feeds and pet foods. These materials provide diets with adequate nutrients and good digestibility (Murray, Patil, Fahey, Merchen, & Hughes, 1997) . In fact, meat and bone meal, blood meal, plasma meal, hydrolyzed feather meal, tallow or grease contain protein, fat, minerals and trace elements as well as B vitamins and some fatsoluble vitamins which are required in animal nutrition (Pearl, 2004) . As mentioned for human food, the functions and usefulness of some organs may vary because of relevant fluctuations in the nutrient content depending on the animal species from which they are obtained.
Different methods for recovering nutrients from animal byproducts and its use as ingredient in feeds have been reported. Some examples are the separation of protein from the animal byproduct materials and drying the meal (Alexis & Robert, 2004) , the production of high-quality amino acid solution from the blood of harvested animals through the use of specific microbial cultures (Giu & Giu, 2010) or the generation of crude protein extracts from keratin, a fibrous structural protein that constitute structural component of hair, nail, feather and outer layer of skin, through enzymatic hydrolysis with keratinase (Deivasigamani & Alagappan, 2008) .
Other non-food, non-feed industrial applications
Rendered fat has expanded its use for a variety of cosmetic applications like hand and body lotions, creams and bath products. Fatty acids are used in a large amount of chemical processes like rubber and plastic polymerization, softeners, lubricants and plasticizers. Collagen, gelatin and glycerin are also used as ingredients for surfactants, paints, varnishes, adhesives, antifreeze, cleaners, polishes and pharmaceuticals (Pearl, 2004) .
In recent years, low cost vegetable and animal fat wastes were used as raw materials for biodiesel production, replacing conventional diesel fuel by fatty acid methyl esters. Biodiesel can be a valid alternative to diesel fuel with non significant modifications to the vehicle engines. Furthermore, it has several additional advantages: it is biodegradable, non toxic and with a favorable combustion emission profile that leads to reductions in carbon dioxide, carbon monoxide, particulate matter and unburned hydrocarbon (Moreira, Dias, Almeida, & Alvim-Ferraz, 2010) . The most common way to produce biodiesel is by transesterification of the fats with a low molecular weight alcohol to yield a mixture of fatty acid methyl esters and glycerol as a side product. Raw materials consist of low cost animal fat by-products like poultry fat or tallow and the transesterification reactions are acid, alkali or enzymaticcatalyzed (Bhatti, Hanif, Qasim, & Rheman, 2008; Moreira et al., 2010) . Other authors propose the use of supercritical transesterification to increase biodiesel profitability for continuous flow processes and without glycerol generation as by-product (Marulanda, Anitescu, & Tavlarides, 2010) . High yields have been reported after hydrodooxygenation and hydroisomerization in tubular reactors (Herskowitz, 2008) .
Hides are traditionally used for conversion into leather (Ockerman & Basu, 2004b) and it is continuing nowadays. For instance, the yield of cattle hide is about 7-8% of the animal's live weight and is classified in accordance to weight, sex, defects and skill of removal. Uses are quite extended and involve shoes, handbags, purses, gloves, fancy leather clothes, belts, etc. Hides also constitute a source of collagen.
Conclusions
There is a large variety of applications of meat by-products. In addition to the usual applications like human and animal foods, rendered fat for cosmetics and chemicals and hides for leather, recent innovative proposals include the use of proteins for better technological or nutritional properties, the generation of bioactive and antimicrobial peptides or the use of animal fats for biodiesel production.
Regardless of the final product's destination, it is still necessary to employ the most up-to-date and effective tools to analyze byproducts for nutritional properties, to search for key active molecules in food and nutrition, as well as for other non-food applications like pharmaceuticals, cosmetics or energy, to continue innovation towards advanced value-addition of such by-products.
